Laurus Labs CEO on the growth prospects of Indian pharma cos in the post-Covid world
We will have to wait and see the Q1 and Q2 performance of companies to gauge who are the winners and losers, says Satyanarayana Chava.
Other News Videos
LIVE | Adani Group Annual General Meeting 2026: Chairman Gautam Adani's address
'Tough times never last, tough nations do': Ambani seeks fresh RIL momentum after Rs 1.5 lakh cr...
$320 billion danger: Why 70 EM funds still remain underweight on India
RIL AGM 2026: Date, Time & 4 Big Things to Watch (Jio IPO, Retail, Energy)
SpaceX IPO LIVE | Elon Musk becomes world's first trillionaire as company makes historic debut